Close Menu
healthylife7.comhealthylife7.com

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    CHPA president and CEO Scott Melville to step down

    August 24, 2026

    Four key ways our warming planet is affecting our health

    August 24, 2026

    Bi-Partisan Bill Proposed to Provide Firefighters, EMS with Mental Health Support

    August 24, 2026
    Facebook X (Twitter) Instagram
    Trending
    • CHPA president and CEO Scott Melville to step down
    • Four key ways our warming planet is affecting our health
    • Bi-Partisan Bill Proposed to Provide Firefighters, EMS with Mental Health Support
    • What’s Good About Teen Gut
    • 2026 Austrian Oak Pro Results: Regan Grimes Qualifies for Mr. Olympia as Michael Daboul Sparks Stage Drama
    • AI Disrupts the Functional Foods and Beverages Sector as Industry Giants Deploy Personalization, Formulation, and Sustainability Technologies at Scale
    • New $700M teaching hospital planned for South Atlanta
    • Time Out fashion and lifestyle brand to launch internationally with TBH Global
    Facebook X (Twitter) Instagram
    healthylife7.comhealthylife7.com
    • Home
    • Fitness
    • Health
    • Nutrition
    • Lifestyle
    • Conditions
    • Mental Health
    • Weight Loss
    • Wellness Tips
    Monday, August 24
    healthylife7.comhealthylife7.com
    Home»Wellness Tips»E3 ligase FBXO2-mediated protein stability of insulin receptor regulates adipogenesis and metabolic health in obesity
    Wellness Tips

    E3 ligase FBXO2-mediated protein stability of insulin receptor regulates adipogenesis and metabolic health in obesity

    healthylife7By healthylife7July 8, 2026No Comments5 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Reddit WhatsApp Email
    E3 ligase FBXO2-mediated protein stability of insulin receptor regulates adipogenesis and metabolic health in obesity
    Share
    Facebook Twitter LinkedIn Pinterest WhatsApp Email

    Download PDF

    Abstract

    Adipogenesis, a crucial physiological process, serves to safely sequester lipids, thereby preventing lipotoxicity in peripheral organs and preserving metabolic health during obesity. While insulin signaling plays a pivotal role in adipogenesis, regulating factors, especially the braking mechanism governing this process, warrant further investigation. Our study identified proteasome-dependent degradation of the insulin receptor (IR) during the early stages of adipogenesis as a critical event for the mitotic clonal expansion phase of the adipocyte differentiation program. A series of studies confirmed that the ubiquitinated modification of IR is regulated by E3 ligase FBXO2, and this is based on IR phosphorylation. We further elucidated that the FBD domain of FBXO2 is indispensable for its function in catalyzing p-IR ubiquitination. Gain or loss of function of Fbxo2 inhibited or promoted SVF or 3T3L1 cells proliferation and adipogenesis both in vitro and in vivo, which regulated adipose hyperplasia and plasticity of adipose tissue. Moreover, FBXO2 played an important role in regulating the metabolic health of mice when subjected to caloric excess. Collectively, our findings unveil FBXO2 as a negative regulator of adipogenesis by impairing the insulin signaling pathway.

    Acknowledgements

    We are grateful for the technical support of the Core Facility Center, Capital Medical University. We thank Dr. Aijuan Qu, Dr. Lin Shan and Dr. Ping Xie from Capital Medical University for their kind help in providing Pdgfrα-Cre mice and experimental support

    Funding

    This work was supported by the Innovative Group Cultivation Project for Basic Medicine (CX25XT03), Project of Cultivation for young top-notch Talents of Beijing Municipal Institutions (BPHR202203106), Beijing Natural Science Foundation of China (5232002), and Beijing Natural Science Foundation of China (5232003)

    Authors and Affiliations

    1. Department of Human Anatomy, School of Basic Medical Sciences, Capital Medical University, Beijing, China

      Yue Xin, Jiaxin Liu, Zhaoyi Zhai, Haofeng Wu, Muchen Wu, Xueqin Wu, Ruiping Wang, Qi Wang, Xiaowei Jia, Lulu Wang, Tao Lu, Dongliang Fang & Yan Gao

    2. Department of Cardiology, Beijing Luhe Hospital, Capital Medical University, Beijing, China

      Yue Xin

    3. Laboratory for Clinical Medicine, Beijing Key Laboratory for Tumor Invasion and Metastasis, Capital Medical University, Beijing, China

      Zhaoyi Zhai, Qi Wang, Lulu Wang, Tao Lu & Yan Gao

    4. Department of Experimental Center for Basic Medical Teaching, School of Basic Medical Sciences, Capital Medical University, Beijing, China

      Hongwei Shang, Xin Lu, Chun Yang & Yan Gao

    5. Sports Medicine Department, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China

      Meng Zhou

    6. Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China

      Yan Gao

    Authors

    1. Yue XinView author publications

      Search author on:PubMed Google Scholar

    2. Jiaxin LiuView author publications

      Search author on:PubMed Google Scholar

    3. Zhaoyi ZhaiView author publications

      Search author on:PubMed Google Scholar

    4. Haofeng WuView author publications

      Search author on:PubMed Google Scholar

    5. Muchen WuView author publications

      Search author on:PubMed Google Scholar

    6. Xueqin WuView author publications

      Search author on:PubMed Google Scholar

    7. Ruiping WangView author publications

      Search author on:PubMed Google Scholar

    8. Qi WangView author publications

      Search author on:PubMed Google Scholar

    9. Xiaowei JiaView author publications

      Search author on:PubMed Google Scholar

    10. Lulu WangView author publications

      Search author on:PubMed Google Scholar

    11. Hongwei ShangView author publications

      Search author on:PubMed Google Scholar

    12. Xin LuView author publications

      Search author on:PubMed Google Scholar

    13. Meng ZhouView author publications

      Search author on:PubMed Google Scholar

    14. Tao LuView author publications

      Search author on:PubMed Google Scholar

    15. Chun YangView author publications

      Search author on:PubMed Google Scholar

    16. Dongliang FangView author publications

      Search author on:PubMed Google Scholar

    17. Yan GaoView author publications

      Search author on:PubMed Google Scholar

    Ethics declarations

    Competing interests

    The authors declare no competing interests

    Ethical approval

    All animal experiments were approved by the Medical Ethics Committee of Capital Medical University

    Additional information

    Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

    Edited by Dr Piero Marchetti

    Supplementary information

    Original Data (download PDF )

    Reproducibility checklist (download PDF )

    Supplementary TableS1 (download XLSX )

    Supplementary TableS2 (download XLSX )

    Supplementary TableS3 (download XLSX )

    Supplementary TableS4 (download XLSX )

    Supplementary FigureS1 (download TIF )

    Supplementary FigureS2 (download TIF )

    Supplementary FigureS3 (download TIF )

    Supplementary FigureS4 (download TIF )

    Supplementary FigureS5 (download TIF )

    Supplementary FigureS6 (download TIF )

    Supplementary FigureS7 (download TIF )

    Supplementary FigureS8 (download TIF )

    Supplementary FigureS9 (download TIF )

    Supplementary FigureS10 (download TIF )

    Supplementary Figure legend (download DOCX )

    Rights and permissions

    Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

    Reprints and permissions

    About this article

    Cite this article

    Xin, Y., Liu, J., Zhai, Z. et al. E3 ligase FBXO2-mediated protein stability of insulin receptor regulates adipogenesis and metabolic health in obesity.
    Cell Death Dis (2026). https://doi.org/10.1038/s41419-026-09096-z

    • Received:09 October 2025

    • Revised:18 June 2026

    • Accepted:29 June 2026

    • Published:08 July 2026

    • DOI
      :https://doi.org/10.1038/s41419-026-09096-z

    FBXO2mediated insulin ligase Protein stability
    healthylife7
    • Website

    Related Posts

    GLP-1 Receptor Agonist Therapy: Management, Maintenance, and Long

    August 24, 2026

    Rhythm Pharmaceuticals Receives Japan Marketing Authorization for IMCIVREE to Treat Acquired Hypothalamic Obesity

    August 24, 2026

    Ozempic and Mounjaro are not easy shortcuts for weight loss: Doctor says why

    August 24, 2026
    Leave A Reply Cancel Reply

    Health
    Lifestyle

    CHPA president and CEO Scott Melville to step down

    By healthylife7August 24, 20260

    Consumer Healthcare Products Association president and CEO Scott Melville plans to step down early next year, ending 16 years at the helm of the self-care industry trade association

    Four key ways our warming planet is affecting our health

    August 24, 2026

    Bi-Partisan Bill Proposed to Provide Firefighters, EMS with Mental Health Support

    August 24, 2026

    What’s Good About Teen Gut

    August 24, 2026
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Fitness

    Opinion: The FDA must put biotech at its center or continue to cede early research to China

    July 6, 2026

    Inside Elevance’s digital chronic disease management strategy

    July 6, 2026

    Best, Worst States For Well

    July 6, 2026

    What do the Middle Ages tell us about mental health then and now? VCU historian Leigh Ann Craig has answers

    July 6, 2026

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us

    Welcome to HealthyLife7.com, your trusted source for reliable health, wellness, fitness, and lifestyle information. Our mission is to help people make informed decisions about their health by providing clear, practical, and easy-to-understand content.

    At HealthyLife7.com, we believe that good health starts with the right knowledge. Whether you're looking for healthy eating tips, fitness advice, mental wellness strategies, weight management guidance, or information about common health conditions, our goal is to deliver valuable content that supports a healthier lifestyle.

    Fitness

    CHPA president and CEO Scott Melville to step down

    August 24, 2026

    Four key ways our warming planet is affecting our health

    August 24, 2026

    Bi-Partisan Bill Proposed to Provide Firefighters, EMS with Mental Health Support

    August 24, 2026
    Health

    Opinion: The FDA must put biotech at its center or continue to cede early research to China

    July 6, 2026

    Inside Elevance’s digital chronic disease management strategy

    July 6, 2026

    Best, Worst States For Well

    July 6, 2026
    Facebook X (Twitter) Instagram Pinterest
    • About Us
    • Contact us
    • Disclaimer
    • Privacy Policy
    • Terms and Conditions
    © 2026 healthylife7.com. Designed by Pro.

    Type above and press Enter to search. Press Esc to cancel.